Mark Kinirons

1.2k total citations
32 papers, 828 citations indexed

About

Mark Kinirons is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Mark Kinirons has authored 32 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Mark Kinirons's work include Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cardiac Arrest and Resuscitation (4 papers). Mark Kinirons is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cardiac Arrest and Resuscitation (4 papers). Mark Kinirons collaborates with scholars based in United Kingdom, United States and Ireland. Mark Kinirons's co-authors include M. S. O'Mahony, Alastair J.J. Wood, Peter Crome, G. Wilkinson, Diarmuid O’Shea, John D. Groopman, Richard B. Kim, Kenneth E. Thummel, Margaret Wood and Adrian Wagg and has published in prestigious journals such as The Lancet, European Heart Journal and Anesthesiology.

In The Last Decade

Mark Kinirons

30 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kinirons United Kingdom 12 347 194 151 114 77 32 828
Michael S. Ching Australia 18 295 0.9× 170 0.9× 195 1.3× 134 1.2× 101 1.3× 48 893
Hitomi Teramachi Japan 16 231 0.7× 212 1.1× 119 0.8× 161 1.4× 67 0.9× 174 1.2k
Harri Luurila Finland 12 399 1.1× 277 1.4× 236 1.6× 140 1.2× 131 1.7× 20 897
K.W. Woodhouse United Kingdom 13 342 1.0× 191 1.0× 196 1.3× 96 0.8× 83 1.1× 23 1.3k
Alison E. Fohner United States 18 322 0.9× 148 0.8× 122 0.8× 107 0.9× 65 0.8× 47 962
Kuntheavy Ing Lorenzini Switzerland 13 232 0.7× 185 1.0× 116 0.8× 194 1.7× 80 1.0× 40 832
Elizabeth Landrum Michalets United States 10 249 0.7× 123 0.6× 105 0.7× 112 1.0× 69 0.9× 16 808
CF George United Kingdom 17 314 0.9× 244 1.3× 258 1.7× 154 1.4× 118 1.5× 28 1.2k
Victoria Rollason Switzerland 18 363 1.0× 203 1.0× 205 1.4× 176 1.5× 129 1.7× 50 1.3k
RA Robson New Zealand 17 343 1.0× 184 0.9× 196 1.3× 248 2.2× 46 0.6× 27 955

Countries citing papers authored by Mark Kinirons

Since Specialization
Citations

This map shows the geographic impact of Mark Kinirons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kinirons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kinirons more than expected).

Fields of papers citing papers by Mark Kinirons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kinirons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kinirons. The network helps show where Mark Kinirons may publish in the future.

Co-authorship network of co-authors of Mark Kinirons

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kinirons. A scholar is included among the top collaborators of Mark Kinirons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kinirons. Mark Kinirons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinirons, Mark, et al.. (2015). Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clinical Medicine. 15(5). 431–436. 35 indexed citations
2.
Kalsi, Tania, et al.. (2011). Tongue swelling in association with oseltamivir (Tamiflu). BMJ Case Reports. 2011. bcr0620114396–bcr0620114396. 3 indexed citations
3.
Fhogartaigh, Caoimhe Nic, William Newsholme, Mark Kinirons, & C. Y. William Tong. (2011). An emerging infectious cause of renal impairment in the UK. BMJ Case Reports. 2011. bcr0620114326–bcr0620114326. 3 indexed citations
4.
Kinirons, Mark & M. S. O'Mahony. (2004). Drug metabolism and ageing. British Journal of Clinical Pharmacology. 57(5). 540–544. 162 indexed citations
5.
Wilson, Ken, et al.. (2003). Clinical pharmacology of old age syndromes. British Journal of Clinical Pharmacology. 56(3). 261–272. 3 indexed citations
6.
Kelly, James & Mark Kinirons. (2003). Intracranial tuberculomas. The Lancet. 362(9386). 797–797. 4 indexed citations
7.
Kinirons, Mark, Diarmuid O’Shea, Richard B. Kim, et al.. (1999). Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A*. Clinical Pharmacology & Therapeutics. 66(3). 224–231. 109 indexed citations
8.
Ouldred, Emma, et al.. (1998). Purpuric rash with donepezil treatment. BMJ. 317(7161). 787.1–787.1. 16 indexed citations
9.
Kinirons, Mark & Peter Crome. (1997). Clinical Pharmacokinetic Considerations in the Elderly. Clinical Pharmacokinetics. 33(4). 302–312. 90 indexed citations
10.
Stewart, Kevin, Adrian Wagg, & Mark Kinirons. (1996). When Can Elderly Patients Be Excluded from Discussing Resuscitation?. Journal of the Royal College of Physicians of London. 30(2). 133–135. 6 indexed citations
11.
Lang, Chim C., Mark Kinirons, F. Peter Guengerich, et al.. (1996). Decreased intestinal CYP3A in celiac disease: Reversal after successful gluten-free diet: A potential source of interindividual variability in first-pass drug metabolism*. Clinical Pharmacology & Therapeutics. 59(1). 41–46. 46 indexed citations
12.
Stein, C. Michael, Mark Kinirons, Theodore Pincus, G. Wilkinson, & Alastair J.J. Wood. (1996). Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine*. Clinical Pharmacology & Therapeutics. 59(1). 47–51. 29 indexed citations
13.
Wagg, Adrian, Mark Kinirons, & Kevin Stewart. (1995). Cardiopulmonary Resuscitation: Doctors and Nurses Expect Too Much. Journal of the Royal College of Physicians of London. 29(1). 20–24. 16 indexed citations
14.
Kinirons, Mark. (1994). Therapeutic Applications of Prostaglandins. British Journal of Clinical Pharmacology. 38(2). 153–153. 3 indexed citations
15.
Stewart, Kevin, Adrian Wagg, & Mark Kinirons. (1994). Does Audit Improve DNR Decision Making?. Journal of the Royal College of Physicians of London. 28(4). 318–321. 4 indexed citations
16.
Kinirons, Mark, et al.. (1994). Metabolism of cytochrome P4503A substrates in vivo administered by the same route: Lack of correlation between alfentanil clearance and erythromycin breath test. Clinical Pharmacology & Therapeutics. 56(6). 608–614. 45 indexed citations
17.
Kinirons, Mark, et al.. (1993). Computerised psychomotor performance testing: a comparative study of the single dose pharmacodynamics of minaprine and amitriptyline in young and elderly subjects. British Journal of Clinical Pharmacology. 36(4). 376–379. 4 indexed citations
18.
Kinirons, Mark. (1993). Newer Agents for the Treatment of MalignantHypercalcemia. The American Journal of the Medical Sciences. 305(6). 403–406. 11 indexed citations
19.
Kinirons, Mark, et al.. (1993). Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clinical Pharmacology & Therapeutics. 54(6). 621–629. 114 indexed citations
20.
Brady, Hugh R., et al.. (1989). Heart rate and metabolic response to competitive squash in veteran players: identification of risk factors for sudden cardiac death. European Heart Journal. 10(11). 1029–1035. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael S. Ching Breakdown of academic impact, for papers by Hitomi Teramachi Breakdown of academic impact, for papers by Harri Luurila Breakdown of academic impact, for papers by K.W. Woodhouse Breakdown of academic impact, for papers by Alison E. Fohner Breakdown of academic impact, for papers by Kuntheavy Ing Lorenzini Breakdown of academic impact, for papers by Elizabeth Landrum Michalets Breakdown of academic impact, for papers by CF George Breakdown of academic impact, for papers by Victoria Rollason Breakdown of academic impact, for papers by RA Robson
Rankless by CCL
2026